This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Luca, F. Articles by Baron, J. Search for Related Content PubMed PubMed Citation Articles by De Luca, F. Articles by Baron, J.

Retinoic Acid Is a Potent Regulator of Growth Plate Chondrogenesis

Developmental Endocrinology Branch (F.D.L., J.A.U., V.M., E.E.M., J.A.Y., K.M.B., J.B.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and Department of Food Science and Human Nutrition (M.H.Z.), Michigan State University, East Lansing, Michigan 48824-1224

Address all correspondence and requests for reprints to: Francesco De Luca, Department of Pediatrics, University of Maryland School of Medicine, 22 South Greene Street, Room N5E13, Baltimore, Maryland 21201-1595. E-mail: fdeluca{at}peds.umaryland.edu

Vitamin A deficiency and excess both cause abnormalities in mammalian longitudinal bone growth. Because all-trans retinoic acid (RA) is synthesized from vitamin A, we hypothesized that RA regulates growth plate chondrogenesis. Consistent with this hypothesis, a single oral dose of RA reduced the height of the rat proximal tibial growth plate. To determine whether RA acts directly on growth plate, fetal rat metatarsal bones were cultured in the presence of RA. In this system, RA inhibited longitudinal bone growth by three mechanisms: 1) decreased chondrocyte proliferation, (assessed by ³H-thymidine incorporation), particularly in the proliferative zone of the growth plate; 2) decreased matrix synthesis (assessed by ³⁵SO₄ incorporation into glycosaminoglycans); and 3) decreased cell hypertrophy (determined histologically). The growth-inhibiting effects of RA were completely reversed by a retinoic acid receptor (RAR) antagonist. In the absence of exogenous RA, this antagonist accelerated bone growth, as did an RA-specific neutralizing antibody, suggesting that endogenous RA negatively regulates growth plate chondrogenesis. We conclude that RA, acting through RARs, negatively regulates longitudinal bone growth by inhibiting growth plate chondrocyte proliferation, chondrocyte hypertrophy, and matrix synthesis.

This article has been cited by other articles:

				S. Simsa, A. Hasdai, H. Dan, and E. M. Ornan Differential regulation of MMPs and matrix assembly in chicken and turkey growth-plate chondrocytes Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2216 - R2224. [Abstract] [Full Text] [PDF]

				P. Brites, A. M. Motley, P. Gressens, P. A.W. Mooyer, I. Ploegaert, V. Everts, P. Evrard, P. Carmeliet, M. Dewerchin, L. Schoonjans, et al. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata Hum. Mol. Genet., September 15, 2003; 12(18): 2255 - 2267. [Abstract] [Full Text] [PDF]

				C. M. Rohde and H. DeLuca Bone Resorption Activity of All-trans Retinoic Acid Is Independent of Vitamin D in Rats J. Nutr., March 1, 2003; 133(3): 777 - 783. [Abstract] [Full Text] [PDF]

				V. Abad, J. L. Meyers, M. Weise, R. I. Gafni, K. M. Barnes, O. Nilsson, J. D. Bacher, and J. Baron The Role of the Resting Zone in Growth Plate Chondrogenesis Endocrinology, May 1, 2002; 143(5): 1851 - 1857. [Abstract] [Full Text] [PDF]

				N. Yagishita, Y. Yamamoto, T. Yoshizawa, K. Sekine, Y. Uematsu, H. Murayama, Y. Nagai, W. Krezel, P. Chambon, T. Matsumoto, et al. Aberrant Growth Plate Development in VDR/RXR{gamma} Double Null Mutant Mice Endocrinology, December 1, 2001; 142(12): 5332 - 5341. [Abstract] [Full Text] [PDF]

				F. De Luca, K. M. Barnes, J. A. Uyeda, S. De-Levi, V. Abad, T. Palese, V. Mericq, and J. Baron Regulation of Growth Plate Chondrogenesis by Bone Morphogenetic Protein-2 Endocrinology, January 1, 2001; 142(1): 430 - 436. [Abstract] [Full Text] [PDF]

				M. J.G. Jimenez, M. Balbin, J. Alvarez, T. Komori, P. Bianco, K. Holmbeck, H. Birkedal-Hansen, J. M. Lopez, and C. Lopez-Otin A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation J. Cell Biol., December 24, 2001; 155(7): 1333 - 1344. [Abstract] [Full Text] [PDF]